Introduction
VeriOsteo OP is the first AI-assisted screening software for bone mineral density (BMD) abnormalities approved by Taiwan FDA. By analyzing chest X-ray images, it predicts the BMD, calculates the T-score from the BMD, and automatically outputs a recommendation on BMD abnormalities with nearly 90% accuracy*. This information assists healthcare professionals in assessing the risk of BMD abnormalities, enabling them to make informed decisions regarding referrals. VeriOsteo OP provides a more convenient option for individuals seeking to screen for BMD abnormalities.
Features / strengths
(1) Batch Analysis
VeriOsteo OP allows users to import multiple chest X-ray images for analysis in a single setting. The analysis results are output in a CSV file for further processing by healthcare institutions.
(2) Personalized Report
VeriOsteo OP offers personalized reports that include chest X-ray images, AI analysis results , BMD, and T-score for each subject analyzed.
(3) Data Management Services
VeriOsteo OP allows users to manage analyzed data by customers with a user-friendly interface and searching and querying features. The system also automatically records AI analyzed results and personalized reports.
Specification in detail
Supporting document
